Stritinib 400mg Tablet

About

Stritinib 400mg Tablet is a targeted therapy medication, typically classified as a tyrosine kinase inhibitor. It works by selectively blocking specific enzymes (tyrosine kinases) that are crucial for cell growth, proliferation, and survival in certain disease states, particularly in various cancers or severe autoimmune conditions. By inhibiting these pathways, Stritinib aims to halt or slow the progression of the disease, reduce tumor size, or modulate an overactive immune response. The 400mg dosage is a standard therapeutic strength, designed to achieve optimal systemic concentrations for its intended action. Due to its potent and specific mechanism, treatment with Stritinib requires careful medical supervision, including regular monitoring of disease markers and potential adverse effects, to ensure both efficacy and patient safety throughout the treatment duration. Adherence to the prescribed regimen is critical for maximizing therapeutic benefits.

Uses

• Treatment of specific types of cancer.
• Management of certain myeloproliferative disorders.
• Therapy for advanced solid tumors.
• Control of severe autoimmune conditions.

Directions For Use

Take one tablet orally with a meal and a full glass of water, once daily, or as directed by your oncologist. Do not crush or chew.

Benefits

• Targets specific disease pathways.
• May inhibit tumor growth or progression.
• Offers a personalized treatment approach.
• Can improve disease-free survival.
• Convenient oral administration.
• Potentially reduces need for more invasive therapies.

Side Effects

• Fatigue
• Nausea
• Diarrhea
• Skin rash
• Headache
• Muscle pain
• Fluid retention
• Elevated liver enzymes
• Hypertension
• Hair thinning
• Loss of appetite
• Mouth sores

Safety Measures

• Alcohol - Avoid or significantly limit alcohol consumption, as it may increase the risk of liver toxicity and other adverse effects.
• Pregnancy - Highly contraindicated in pregnancy due to significant risk of fetal harm. Effective contraception is required during treatment and for a period after.
• Breastfeeding - Breastfeeding is not recommended during treatment and for a specified period after the last dose, as the drug can pass into breast milk.
• Liver - Use with extreme caution in patients with liver impairment; frequent monitoring of liver function tests is crucial, and dose adjustments are often necessary.
• Kidney - Exercise caution in patients with renal dysfunction; dose modifications may be required based on kidney function and close monitoring.
• Lung - Monitor for new or worsening respiratory symptoms, as interstitial lung disease or pneumonitis can be a rare but serious side effect.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.